Fingolimod Increases CD39-Expressing Regulatory T Cells in Multiple Sclerosis Patients
Published 2014 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Fingolimod Increases CD39-Expressing Regulatory T Cells in Multiple Sclerosis Patients
Authors
Keywords
-
Journal
PLoS One
Volume 9, Issue 11, Pages e113025
Publisher
Public Library of Science (PLoS)
Online
2014-11-21
DOI
10.1371/journal.pone.0113025
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Suppressed pro-inflammatory properties of circulating B cells in patients with multiple sclerosis treated with fingolimod, based on altered proportions of B-cell subpopulations
- (2014) Yusei Miyazaki et al. CLINICAL IMMUNOLOGY
- Sphingosine-1-phosphate receptor 1 signalling in T cells: trafficking and beyond
- (2014) Christopher S. Garris et al. IMMUNOLOGY
- Anti-Inflammatory Effects of FTY720 against Viral-Induced Immunopathology: Role of Drug-Induced Conversion of T Cells to Become Foxp3+ Regulators
- (2014) S. Sehrawat et al. JOURNAL OF IMMUNOLOGY
- Fingolimod Modulates Peripheral Effector and Regulatory T Cells in MS Patients
- (2013) Laura D. Serpero et al. Journal of Neuroimmune Pharmacology
- Upregulation of IL-17, but not of IL-9, in circulating cells of CIS and relapsing MS patients. Impact of corticosteroid therapy on the cytokine network
- (2012) Nathalie Muls et al. JOURNAL OF NEUROIMMUNOLOGY
- FTY720-Induced Conversion of Conventional Foxp3−CD4+ T Cells to Foxp3+ Regulatory T Cells in NOD Mice
- (2011) Yun Sun et al. AMERICAN JOURNAL OF REPRODUCTIVE IMMUNOLOGY
- Genetic risk and a primary role for cell-mediated immune mechanisms in multiple sclerosis
- (2011) Stephen Sawcer et al. NATURE
- IL-22RA2 Associates with Multiple Sclerosis and Macrophage Effector Mechanisms in Experimental Neuroinflammation
- (2010) A. D. Beyeen et al. JOURNAL OF IMMUNOLOGY
- Activation of the aryl hydrocarbon receptor induces human type 1 regulatory T cell–like and Foxp3+ regulatory T cells
- (2010) Roopali Gandhi et al. NATURE IMMUNOLOGY
- CD4 + CD25 + regulatory T cells partially mediate the beneficial effects of FTY720, a sphingosine-1-phosphate analogue, during ischaemia/reperfusion-induced acute kidney injury
- (2010) M.-G. Kim et al. NEPHROLOGY DIALYSIS TRANSPLANTATION
- Th17 central memory T cells are reduced by FTY720 in patients with multiple sclerosis
- (2010) M. Mehling et al. NEUROLOGY
- The Inflammasomes: Guardians of the Body
- (2009) Fabio Martinon et al. Annual Review of Immunology
- The Sphingosine 1-Phosphate Receptor Agonist FTY720 Potently Inhibits Regulatory T Cell Proliferation In Vitro and In Vivo
- (2009) A. M. Wolf et al. JOURNAL OF IMMUNOLOGY
- CD39+Foxp3+ Regulatory T Cells Suppress Pathogenic Th17 Cells and Are Impaired in Multiple Sclerosis
- (2009) J. M. Fletcher et al. JOURNAL OF IMMUNOLOGY
- The receptor S1P1 overrides regulatory T cell–mediated immune suppression through Akt-mTOR
- (2009) Guangwei Liu et al. NATURE IMMUNOLOGY
- The aryl hydrocarbon receptor links TH17-cell-mediated autoimmunity to environmental toxins
- (2008) Marc Veldhoen et al. NATURE
- Control of Treg and TH17 cell differentiation by the aryl hydrocarbon receptor
- (2008) Francisco J. Quintana et al. NATURE
- FTY720 therapy exerts differential effects on T cell subsets in multiple sclerosis
- (2008) M. Mehling et al. NEUROLOGY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExplorePublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More